2019: News Archive
Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.
Michigan Drug Discovery has awarded pilot funding to projects working on innovative approaches to treat fibrotic diseases, neurodegenerative disorders, diverticulitis, autoimmune diseases and several forms of cancer.
A new study finds that U-M-designed compounds led to significantly smaller, slower growing tumors.
President Mark Schlissel’s Biosciences Initiative is offering a new funding opportunity to improve core research resources across the University of Michigan.
Michigan Drug Discovery has awarded early-stage funding for five new projects by faculty from across U-M, with the the goals of discovering new drugs for treating cancer, rheumatoid arthritis, and heart disease and creating new non-opioid painkillers.
The Regents of the University of Michigan (U-M) will expand the U-M Biomedical Seed Fund that provides equity-based investments in U-M life science spin outs.